Linkage Projects - Grant ID: LP0882596

Funding Activity

Website
http://dataportal.arc.gov.au/NCGP/Web/Grant/Grant/LP0882596

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Nanotechnology-Enhanced Vaccines: New inulin bioconjugates to defeat global pandemic threats. Inulin-based adjuvants have the potential to revolutionise the vaccine arena; man's critical first line of defence against infectious disease. Any breakthrough in developing completely safe new adjuvants, will therefore be of major global significance, and will play a vital role in the maintenance of global health for decades. New and completely safe vaccine adjuvants are a vital step in the development of improved vaccine technology in the 21st century. This project addresses two National Research Priorities, Namely Promoting and Maintaining Good Health and Safeguarding Australia. On commercialization, this will then be an important Australian contribution towards protecting the nation against any future pandemic outbreaks.

Funded Activity Details

Start Date: 30-11-2008

End Date: 29-02-2012

Funding Scheme: Linkage Projects

Funding Amount: $135,000.00

Funder: Australian Research Council

Research Topics

ANZSRC Field of Research (FoR)

Other Instrumental Methods | Biological And Medical Chemistry | Macromolecular and Materials Chemistry | Characterisation Of Macromolecules

ANZSRC Socio-Economic Objective (SEO)

Prevention—biologicals (e.g. vaccines) |

Other Keywords

Biological And Medical Chemistry | Characterisation Of Macromolecules | Macromolecular and Materials Chemistry | Other Instrumental Methods | Prevention—biologicals (e.g. vaccines)

Related Links